JP2009506044A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506044A5 JP2009506044A5 JP2008528086A JP2008528086A JP2009506044A5 JP 2009506044 A5 JP2009506044 A5 JP 2009506044A5 JP 2008528086 A JP2008528086 A JP 2008528086A JP 2008528086 A JP2008528086 A JP 2008528086A JP 2009506044 A5 JP2009506044 A5 JP 2009506044A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- subject
- rosehips
- inflammatory response
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000008536 Vaccinium myrtillus Species 0.000 claims 12
- 239000003814 drug Substances 0.000 claims 12
- 230000028709 inflammatory response Effects 0.000 claims 9
- 230000000051 modifying Effects 0.000 claims 8
- 235000018811 Aframomum Nutrition 0.000 claims 6
- 241001127758 Aframomum Species 0.000 claims 6
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Resveratrol Natural products C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims 6
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims 6
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims 6
- 230000015572 biosynthetic process Effects 0.000 claims 6
- 235000021029 blackberry Nutrition 0.000 claims 6
- 235000021014 blueberries Nutrition 0.000 claims 6
- 239000005550 inflammation mediator Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 238000003786 synthesis reaction Methods 0.000 claims 6
- 230000002194 synthesizing Effects 0.000 claims 6
- 235000015872 dietary supplement Nutrition 0.000 claims 3
- 235000021283 resveratrol Nutrition 0.000 claims 3
- 229940016667 resveratrol Drugs 0.000 claims 3
- 108010002352 Interleukin-1 Proteins 0.000 claims 1
- 230000001105 regulatory Effects 0.000 claims 1
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71073005P | 2005-08-23 | 2005-08-23 | |
PCT/US2006/032847 WO2007024901A1 (en) | 2005-08-23 | 2006-08-23 | Cytokine modulators and related methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009506044A JP2009506044A (ja) | 2009-02-12 |
JP2009506044A5 true JP2009506044A5 (es) | 2010-04-08 |
Family
ID=37575241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008528086A Pending JP2009506044A (ja) | 2005-08-23 | 2006-08-23 | サイトカインの調節物質及び関連する使用方法 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2009506044A (es) |
KR (1) | KR20080041703A (es) |
CN (1) | CN101291681A (es) |
WO (1) | WO2007024901A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009030351A1 (de) * | 2009-06-22 | 2010-12-23 | Gelita Ag | Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen |
KR101056129B1 (ko) * | 2009-12-15 | 2011-08-11 | 주식회사 엘지생활건강 | 항염증용 조성물 |
ES2655885T3 (es) * | 2010-09-22 | 2018-02-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Uso de ácidos boswélicos para la profilaxis y/o tratamiento de daños y/o inflamación de los islotes de Langerhans |
CN102258191B (zh) * | 2010-12-23 | 2012-12-19 | 天津天狮生物发展有限公司 | 预防慢性炎症的抗氧化保健食品及制备方法 |
ITMI20121570A1 (it) * | 2012-09-20 | 2014-03-21 | Indena Spa | Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica |
KR101944113B1 (ko) * | 2017-09-28 | 2019-01-30 | 동의대학교 산학협력단 | 급성 안면통증 예방 및 개선용 조성물 |
TWI732147B (zh) * | 2018-10-26 | 2021-07-01 | 臺北醫學大學 | 用於抑制乙醯膽鹼酯酶之萃取物及組合物 |
CN109907144A (zh) * | 2019-04-19 | 2019-06-21 | 陕西科技大学 | 一种具有控制血糖功效的蓝莓荨麻茶及其制备方法 |
FR3096893B1 (fr) * | 2019-06-06 | 2022-08-05 | Laboratoire Exact | Composition a base d’extrait de jeunes pousses et utilisation pour la prevention et le traitement des maladies liees au vieillissement |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6024960A (en) * | 1998-04-17 | 2000-02-15 | Otto Torbjorn Hansen And Marianne Hansen | Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
DE10153949A1 (de) * | 2000-11-07 | 2002-08-01 | Engelbert Grzeschik | Verwendung von Beerensamenölen |
CN1882354B (zh) * | 2003-09-12 | 2012-07-04 | 捷通国际有限公司 | 细胞因子调节剂及相关用法 |
CN1902325A (zh) * | 2003-09-12 | 2007-01-24 | 捷通国际有限公司 | 用于调节健康状况的项目 |
WO2005112965A2 (en) * | 2004-05-20 | 2005-12-01 | Rutgers, The State University Of New Jersey | Botanical anti-inflammatory compositions and methods |
-
2006
- 2006-08-23 WO PCT/US2006/032847 patent/WO2007024901A1/en active Application Filing
- 2006-08-23 KR KR1020087006426A patent/KR20080041703A/ko not_active Application Discontinuation
- 2006-08-23 CN CNA2006800392181A patent/CN101291681A/zh active Pending
- 2006-08-23 JP JP2008528086A patent/JP2009506044A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009506044A5 (es) | ||
HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
HRP20240317T1 (hr) | Liječenje hepatičke encefalopatije uporabom rifaksimina | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
HRP20200600T1 (hr) | Tapentadol za sprječavanje i liječenje depresije i tjeskobe | |
JP2009523455A5 (es) | ||
MX343358B (es) | Tabletas de acetato de ulipristal. | |
NO20090095L (no) | Anvendelse av en hydrofil matriks omfattende et polyakrylsyrederivat, en cellulose-eter og et disintegreringsmiddel for fremstilling av et medikament for behandling av kvinners genitale forstyrrelser | |
MX348491B (es) | Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco. | |
JP2007527914A5 (es) | ||
IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
JP2010527347A5 (es) | ||
MX2014001167A (es) | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco. | |
JP2008515980A5 (es) | ||
MX2013014788A (es) | Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos. | |
JP2007523135A5 (es) | ||
CO5190672A1 (es) | Composicion para la dosificacion oral, de disolucion instantanea | |
JP2010520246A5 (es) | ||
MX2010004323A (es) | Formas de dosificacion oral que comprenden acetato de licarbazepina. | |
JP2006305390A5 (es) | ||
JP2010525055A5 (es) | ||
JP2009537554A5 (es) | ||
JP2009516719A5 (es) | ||
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
JP2019089796A5 (es) |